Selinexor, bortezomib, and dexamethasone (SVD) in heavily treated relapsed refractory multiple myeloma

Ann Hematol. 2021 Dec;100(12):3057-3060. doi: 10.1007/s00277-020-04293-y. Epub 2020 Oct 2.

¹ Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, 10029, USA.
² Department of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, 10 East 102nd Street, 6th Floor, New York, NY, 10029, USA.
³ Karyopharm Therapeutics, Newton, MA, 02459, USA.
⁴ Department of Hematology/Oncology, Icahn School of Medicine at Mount Sinai, Tisch Cancer Institute, 10 East 102nd Street, 6th Floor, New York, NY, 10029, USA. deepu.madduri@mountsinai.org.

No abstract available

Publication types